Lupin’s wholly owned subsidiary -- Lupin Diagnostics (LDL) has achieved 100% National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation across all its greenfield labs. This notable achievement highlights the adherence to rigorous quality control measures, reinforcing LDL’s unwavering dedication to providing top-tier diagnostic services. The company’s commitment to quality is reflected in every aspect of its operations, ensuring patients receive accurate and timely results that they can trust.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
